Harbin Gloria Pharmaceuticals Co., Ltd
SZSE:002437.SZ
2.21 (CNY) • At close October 26, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets: | |||||||||||||||||
Current Assets: | |||||||||||||||||
Cash & Cash Equivalents
| 711.275 | 1,237.743 | 1,495.713 | 895.445 | 1,311.775 | 1,305.013 | 961.794 | 1,201.834 | 1,193.363 | 1,071.154 | 829.923 | 1,262.704 | 1,453.523 | 1,538.323 | 87.966 | 42.287 | 41.399 |
Short Term Investments
| 0 | 50.564 | -10.849 | -24.138 | -35.267 | -47.185 | -31.594 | -21.655 | -19.723 | -6.688 | 270 | 80 | -1.202 | 0 | 0 | 0 | 0 |
Cash and Short Term Investments
| 711.275 | 1,288.307 | 1,495.713 | 895.445 | 1,311.775 | 1,305.013 | 961.794 | 1,201.834 | 1,193.363 | 1,071.154 | 1,099.923 | 1,342.704 | 1,453.523 | 1,538.323 | 87.966 | 42.287 | 41.399 |
Net Receivables
| 241.136 | 302.835 | 342.323 | 500.656 | 1,385.01 | 1,039.097 | 562.674 | 485.311 | 542.02 | 289.029 | 363.977 | 617.034 | 360.351 | 320.661 | 166.729 | 158.251 | 83.135 |
Inventory
| 190.667 | 214.136 | 352.092 | 370.956 | 455.631 | 446.333 | 469.313 | 271.256 | 277.421 | 163.445 | 120.58 | 67.538 | 72.474 | 53.265 | 23.568 | 19.937 | 14.78 |
Other Current Assets
| 11.372 | 10.919 | 10.296 | 18.049 | 50.663 | 25.629 | 36.007 | 53.988 | 50.71 | 10.618 | -57.007 | -120.372 | -66.998 | -76.799 | -46.867 | -55.764 | -26.58 |
Total Current Assets
| 1,154.45 | 1,816.198 | 2,200.424 | 1,785.106 | 3,203.079 | 2,816.073 | 2,029.789 | 2,012.389 | 2,063.514 | 1,534.245 | 1,527.473 | 1,906.905 | 1,819.35 | 1,835.449 | 231.396 | 164.711 | 112.733 |
Non-Current Assets: | |||||||||||||||||
Property, Plant & Equipment, Net
| 1,064.657 | 1,119.434 | 1,235.273 | 1,339.717 | 1,501.458 | 1,720.441 | 1,778.417 | 1,814.943 | 1,644.949 | 831.401 | 601.894 | 506.856 | 373.15 | 254.025 | 115.513 | 91.311 | 82.03 |
Goodwill
| 369.032 | 369.032 | 411.16 | 411.16 | 411.16 | 3,360.234 | 3,641.24 | 3,683.213 | 3,623.157 | 1,848.291 | 407.774 | 34.17 | 34.17 | 0 | 0 | 0 | 0 |
Intangible Assets
| 199.531 | 225.692 | 296.702 | 355.147 | 435.164 | 618.179 | 706.341 | 462.292 | 482.282 | 403.553 | 387.733 | 97.326 | 78.422 | 32.283 | 21.615 | 19.583 | 18.649 |
Goodwill and Intangible Assets
| 568.563 | 594.725 | 707.863 | 766.307 | 846.325 | 3,978.412 | 4,347.58 | 4,145.505 | 4,105.439 | 2,251.844 | 795.507 | 131.496 | 112.592 | 32.283 | 21.615 | 19.583 | 18.649 |
Long Term Investments
| 330.703 | 407.682 | 509.181 | 579.218 | 682.123 | 813.728 | 549.421 | 502.023 | 174.402 | 17.989 | -264.919 | -74.919 | 2.283 | 0 | 0 | 0 | 0 |
Tax Assets
| 21.009 | 33.773 | 24.188 | 29.949 | 155.791 | 125.573 | 75.349 | 36.277 | 24.387 | 12.071 | 10.68 | 5.98 | 4.882 | 1.414 | 1.532 | 1.227 | 1.017 |
Other Non-Current Assets
| 13.068 | 102.374 | 18.215 | 16.013 | 18.805 | 22.946 | 283.589 | 155.408 | 305.67 | 274.799 | 272.345 | 88.289 | -0.004 | 71.3 | 72.42 | 2.378 | 1.081 |
Total Non-Current Assets
| 1,998 | 2,257.988 | 2,494.719 | 2,731.204 | 3,204.501 | 6,661.1 | 7,034.356 | 6,654.156 | 6,254.846 | 3,388.104 | 1,415.508 | 657.702 | 492.903 | 359.021 | 211.081 | 114.499 | 102.777 |
Total Assets
| 3,152.45 | 4,074.186 | 4,695.144 | 4,516.311 | 6,407.58 | 9,477.173 | 9,064.144 | 8,666.544 | 8,318.36 | 4,922.35 | 2,942.981 | 2,564.606 | 2,312.254 | 2,194.47 | 442.477 | 279.21 | 215.51 |
Liabilities & Equity: | |||||||||||||||||
Current Liabilities: | |||||||||||||||||
Account Payables
| 69.876 | 75.481 | 270.487 | 284.363 | 302.029 | 316.149 | 183.623 | 124.628 | 187.352 | 76.891 | 49.962 | 35.305 | 37.617 | 12.665 | 11.048 | 9.586 | 7.511 |
Short Term Debt
| 674.86 | 1,454.973 | 1,558.129 | 1,352.445 | 2,677.544 | 2,123.087 | 2,114.901 | 2,747.227 | 3,317.63 | 950.992 | 0 | 10 | 0 | 0 | 92 | 52 | 35 |
Tax Payables
| 9.675 | 47.508 | 32.305 | 32.269 | 74.994 | 163.748 | 99.74 | 98.742 | 86.127 | 67.39 | 39.784 | 19.269 | 8.766 | 26.694 | 25.131 | 7.334 | 4.354 |
Deferred Revenue
| 50.027 | 83.165 | 836.201 | 887.739 | 1,712.367 | 163.748 | 835.734 | 461.537 | 353.88 | 342.911 | 0 | 139.563 | 0 | 0 | 48.901 | 21.668 | 33.044 |
Other Current Liabilities
| 617.465 | 722.69 | 13.512 | 15.954 | 74.005 | 1,414.65 | 139.039 | 186.766 | 143.475 | 68.467 | 396.283 | 1.921 | 43.657 | 61.062 | 2.998 | 1.632 | 0.23 |
Total Current Liabilities
| 1,412.228 | 2,336.31 | 2,678.329 | 2,540.501 | 4,765.945 | 4,017.634 | 3,273.297 | 3,520.158 | 4,002.338 | 1,439.26 | 446.245 | 186.789 | 81.274 | 73.728 | 154.947 | 84.885 | 75.785 |
Non-Current Liabilities: | |||||||||||||||||
Long Term Debt
| 0 | 0 | 0 | 10.936 | 1.275 | 996.763 | 1,455.473 | 972.766 | 300 | 336.703 | -15.368 | 15 | 30 | 0 | 0 | 0 | 1.072 |
Deferred Revenue Non-Current
| 17.874 | 21.433 | 24.525 | 28.318 | 32.717 | 40.125 | 47.492 | 49.937 | 39.043 | 15.776 | 15.368 | 0 | 0 | 0 | 0 | 0 | 0 |
Deferred Tax Liabilities Non-Current
| 12.117 | 12.874 | 12.551 | 13.733 | 19.145 | 26.127 | 28.252 | 31.127 | 33.277 | 10.765 | 2.99 | 0.604 | 3.038 | 0 | 0 | 0 | 0.01 |
Other Non-Current Liabilities
| -17.874 | 0.028 | 0.825 | -10.11 | 0 | 2.714 | 7.097 | 45.92 | 470.916 | 17.656 | 15.368 | 1.396 | 0.596 | 0 | 0 | 0.28 | 0.28 |
Total Non-Current Liabilities
| 12.117 | 34.335 | 37.901 | 42.877 | 53.137 | 1,065.729 | 1,538.314 | 1,099.751 | 843.236 | 380.899 | 18.358 | 17 | 33.634 | 0 | 0 | 0.28 | 1.362 |
Total Liabilities
| 1,424.345 | 2,370.645 | 2,716.23 | 2,583.377 | 4,819.082 | 5,083.363 | 4,811.61 | 4,619.909 | 4,845.574 | 1,820.159 | 464.603 | 203.789 | 114.907 | 73.728 | 154.947 | 85.165 | 77.147 |
Equity: | |||||||||||||||||
Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Common Stock
| 2,198.123 | 2,198.123 | 2,198.123 | 2,198.123 | 2,198.123 | 2,198.123 | 2,198.123 | 2,198.29 | 733.01 | 731.89 | 280 | 280 | 280 | 140 | 105 | 105 | 38 |
Retained Earnings
| -913.507 | -1,033.841 | -1,085.726 | -873.6 | -1,273.649 | 1,362.178 | 1,336.408 | 1,186.1 | 1,463.119 | 918.596 | 520.518 | 477.213 | 327.367 | 297.153 | 154.847 | 73.698 | 91.032 |
Accumulated Other Comprehensive Income/Loss
| -1.362 | 64.2 | 367.308 | 107.198 | 207.289 | 377.071 | 271.574 | 233.684 | 172.111 | 0 | -0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Total Stockholders Equity
| 378.519 | 402.755 | 414.508 | 414.508 | 389.601 | 386.64 | 367.812 | 345.017 | 1,034.873 | 1,370.735 | 1,590.602 | 1,575.647 | 1,560.723 | 1,683.59 | 27.683 | 15.347 | 9.268 |
Total Shareholders Equity
| 1,661.773 | 1,631.238 | 1,894.213 | 1,846.228 | 1,521.364 | 4,324.011 | 4,173.917 | 3,963.091 | 3,403.113 | 3,021.221 | 2,391.12 | 2,332.861 | 2,168.091 | 2,120.742 | 287.529 | 194.044 | 138.3 |
Total Equity
| 1,710.231 | 1,703.541 | 1,978.914 | 1,932.934 | 1,588.498 | 4,393.81 | 4,252.534 | 4,046.635 | 3,472.786 | 3,102.19 | 2,478.378 | 2,360.817 | 2,197.346 | 2,120.742 | 287.529 | 194.044 | 138.363 |
Total Liabilities & Shareholders Equity
| 3,152.45 | 4,074.186 | 4,695.144 | 4,516.311 | 6,407.58 | 9,477.173 | 9,064.144 | 8,666.544 | 8,318.36 | 4,922.35 | 2,942.981 | 2,564.606 | 2,312.254 | 2,194.47 | 442.477 | 279.21 | 215.51 |